These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37410123)

  • 1. Impact of Valve Academic Research Consortium 3 (VARC-3) minor access site vascular complications in patients undergoing percutaneous transfemoral transcatheter aortic valve implantation.
    Piperata A; Van den Eynde J; Pernot M; Avesani M; Seguy B; Bonnet G; Ben Ali W; Leroux L; Labrousse L; Modine T
    Eur J Cardiothorac Surg; 2023 Aug; 64(2):. PubMed ID: 37410123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in vascular complications and associated treatment strategies following transfemoral transcatheter aortic valve replacement.
    Ullery BW; Jin R; Kirker EB; Hayes G; Siwek L; Brevig J; Hodson RW; Spinelli KJ
    J Vasc Surg; 2020 Oct; 72(4):1313-1324.e5. PubMed ID: 32169358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound-guided deployment of ProGlide™ device in transfemoral transcatheter aortic valve implantation and risk reduction of vascular complications: A propensity-matched cohort study.
    Ross DS; Nogic J; Cong H; Nuzzi V; Thanikachalam P; Veenuraju S; Gruner-Hegge N; Anwar M; O'Sullivan M; Costopoulos C; Davies WR; Costanzo P
    Catheter Cardiovasc Interv; 2024 Apr; 103(5):771-781. PubMed ID: 38451155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, Prognosis and Predictors of Major Vascular Complications and Percutaneous Closure Device Failure Following Contemporary Percutaneous Transfemoral Transcatheter Aortic Valve Replacement.
    Batchelor W; Patel K; Hurt J; Totten J; Burroughs P; Smith G; Cuervo M; Davis L; Damluji AA; Epps K; Sherwood M; Barnett S; Geloo N; Yazdani S; Sarin E; Ryan L; Noel T
    Cardiovasc Revasc Med; 2020 Sep; 21(9):1065-1073. PubMed ID: 31974033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed Tomographic Angiography-Derived Risk Factors for Vascular Complications in Percutaneous Transfemoral Transcatheter Aortic Valve Implantation.
    Urbach J; Hou CR; Lesser JR; Stanberry LI; Garberich RF; Caye D; Sorajja P; Gössl M
    Am J Cardiol; 2019 Jul; 124(1):98-104. PubMed ID: 31029410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of outcomes with surgical cut-down versus percutaneous transfemoral transcatheter aortic valve replacement: TAVR transfemoral access comparisons between surgical cut-down and percutaneous approach.
    Drafts BC; Choi CH; Sangal K; Cammarata MW; Applegate RJ; Gandhi SK; Kincaid EH; Kon N; Zhao DX
    Catheter Cardiovasc Interv; 2018 Jun; 91(7):1354-1362. PubMed ID: 29024382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous Versus Surgical Cutdown Access for Transfemoral Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-Analysis Focusing on Propensity-Score Matched Studies.
    Riaz S; Kasam Shiva PK; Manimekalai Krishnamurthi JS; Shah RS; Cherukuri AMK; Bhatia P; Arul S; Multani M; Singh A; Suyambu J; Asif K; Al-Tawil M
    Heart Lung Circ; 2024 Oct; 33(10):1393-1403. PubMed ID: 39179438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular complications after transcatheter aortic valve implantation and their association with mortality reevaluated by the valve academic research consortium definitions.
    Steinvil A; Leshem-Rubinow E; Halkin A; Abramowitz Y; Ben-Assa E; Shacham Y; Bar-Dayan A; Keren G; Banai S; Finkelstein A
    Am J Cardiol; 2015 Jan; 115(1):100-6. PubMed ID: 25456874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How accurate are manufacturers' recommendations in determining ineligibility for transfemoral transcatheter aortic valve implantation?
    Çakal B; Çakal S; Karaca O; Yilmaz FK; Gunes HM; Yıldırım A; Guler Y; Ozcan ÖU; Boztosun B
    Rev Port Cardiol; 2023 Jan; 42(1):31-38. PubMed ID: 36328866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular complications after transcatheter aortic valve implantation: treatment modalities and long-term clinical impact.
    Lunardi M; Pighi M; Banning A; Reimers B; Castriota F; Tomai F; Venturi G; Pesarini G; Scarsini R; Kotronias R; Regazzoli D; Maurina M; Nerla R; De Persio G; Ribichini FL
    Eur J Cardiothorac Surg; 2022 Mar; 61(4):934-941. PubMed ID: 35188566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of vascular complications after transcatheter aortic valve implantation. VASC-OBSERVANT II sub-study.
    Aurigemma C; Trani C; D'Errigo P; Barbanti M; Biancari F; Tarantini G; Santoro G; Baiocchi M; Baglio G; Seccareccia F; Rosato S;
    Catheter Cardiovasc Interv; 2023 Aug; 102(2):381-391. PubMed ID: 37265025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of suture mediated femoral access site closure with the Prostar XL compared to the ProGlide system on outcome in transfemoral aortic valve implantation.
    Seeger J; Gonska B; Rodewald C; Rottbauer W; Wöhrle J
    Int J Cardiol; 2016 Nov; 223():564-567. PubMed ID: 27561160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimally invasive versus transapical versus transfemoral aortic valve implantation: A one-to-one-to-one propensity score-matched analysis.
    Furukawa N; Kuss O; Emmel E; Scholtz S; Scholtz W; Fujita B; Ensminger S; Gummert JF; Börgermann J
    J Thorac Cardiovasc Surg; 2018 Nov; 156(5):1825-1834. PubMed ID: 29861110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictability and Outcome of Vascular Complications after Transfemoral Transcatheter Aortic Valve Implantation.
    Uguz E; Gokcimen M; Ali S; Alsancak Y; Bastug S; Ahmet Kasapkara H; Canyigit M; Hıdıroglu M; Sener E
    J Heart Valve Dis; 2016 Mar; 25(2):173-181. PubMed ID: 27989061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimalistic Approach for Transcatheter Aortic Valve Implantation (TAVI): Open Vascular Vs. Fully Percutaneous Approach.
    Kedev S; Zafirovska B; Srbinovska-Kostovska E; Antov S; Nikolic A; Dzemali O; Bunc M
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 Oct; 40(2):5-14. PubMed ID: 31605589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular Complications and Bleeding After Transfemoral Transcatheter Aortic Valve Implantation Performed Through Open Surgical Access.
    Leclercq F; Akodad M; Macia JC; Gandet T; Lattuca B; Schmutz L; Gervasoni R; Nogue E; Nagot N; Levy G; Maupas E; Robert G; Targosz F; Vernhet H; Cayla G; Albat B
    Am J Cardiol; 2015 Nov; 116(9):1399-404. PubMed ID: 26414600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of vascular complications following transcatheter aortic valve implantation.
    Perrin N; Ellenberger C; Licker M; Hachulla AL; Cikirikcioglu M; Frei A; Roffi M; Noble S
    Arch Cardiovasc Dis; 2015 Oct; 108(10):491-501. PubMed ID: 26073229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) japanese multicenter registry.
    Kodama A; Yamamoto M; Shimura T; Kagase A; Koyama Y; Tada N; Takagi K; Araki M; Yamanaka F; Shirai S; Watanabe Y; Hayashida K
    Catheter Cardiovasc Interv; 2017 Sep; 90(3):E55-E62. PubMed ID: 27785881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel echo-guided ProGlide technique during percutaneous transfemoral transcatheter aortic valve implantation.
    Honda Y; Araki M; Yamawaki M; Tokuda T; Tsutumi M; Mori S; Sakamoto Y; Kobayashi N; Hirano K; Ito Y
    J Interv Cardiol; 2018 Apr; 31(2):216-222. PubMed ID: 29193337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successfully Managed Access-Site Complication Was Not Associated With Worse Outcome After Percutaneous Transfemoral Transcatheter Aortic Valve Implantation: Up-to-Date Insights From the OCEAN-TAVI Registry.
    Honda Y; Yamawaki M; Nakano T; Makino K; Ito Y; Yashima F; Tada N; Naganuma T; Yamanaka F; Mizutani K; Tabata M; Ueno H; Takagi K; Watanabe Y; Yamamoto M; Shirai S; Hayashida K;
    Cardiovasc Revasc Med; 2022 May; 38():11-18. PubMed ID: 34391679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.